P ublic health officials are sounding the alarm about the epidemic of diabetes in the US. One in three Americans born in 2000 will develop diabetes in his or her lifetime and more than 29 million Americans will be diagnosed by 2050, according to the US Centers for Disease Control and Prevention (CDC). The American Diabetes Association (ADA) reports that the disease is the sixth leading cause of death in the US. However, this number may be low because diabetes is not listed as the cause of mortality on the death certificates of many of those who die with the disease or related complications.
The complications of diabetes include heart disease, stroke, and high blood pressure. Diabetes is the leading cause of new cases of blindness, serious kidney disease, nervous system damage, and amputations. Per capita health care cost for people with diabetes is more than five times that for people without the disease. The impact on health care costs is staggering: Medical expenditures for diabetes topped $132 billion in 2002 and accounted for one of every 10 health care dollars spent in the US.
Several lifestyle-related risk factors in the US -including the prevalence of fast food, large food portions, obesity, poor nutritional choices, and lack of regular exercisehave increased the risk of developing diabetes. Similar lifestyle changes have occurred in other parts of the world. According to the World Health Organization, diabetes cases in developing countries will double by 2030.
Diabetes self-management education is an integral component of medical care, with pharmacists playing a key role in the management of patients with diabetes. Many hospital and community pharmacies are taking on a more proactive role against the disease.
Pharmacy education programs are taking notice of the trends. At Washington State University (WSU) and other pharmacy schools across the country, students in the professional pharmacy program (PharmD) receive hands-on training in diabetes disease management, according to William E. Fassett, Dean of WSU's College of Pharmacy.
Thanks to the leadership of noted diabetes researcher and educator R. Keith Campbell and his colleagues at WSU, students graduate with a high degree of awareness of the pharmacist's role in the treatment and prevention of diabetes, Fassett says.
"We have finally convinced most health professionals that the patient needs to 'take charge of his/her diabetes' and to do this, the patient needs to be educated and motivated to follow standards of diabetes care," says Campbell. "We now have numerous new medications to treat insulin resistance and new methods to administer insulin are close to being approved. Much research is being done to better understand the complications of diabetes and how to prevent them. This is one of the most exciting areas of research that I have seen in my more than 53 years of having diabetes and in my 35 years of teaching and research at Washington State."
In his career, Campbell has made over 600 presentations to health care workers -reaching an estimated 30,000 practitioners -and has published more than 650 articles. He has trained approximately 1,500 pharmacist practitioners in diabetes care as well as the students who have graduated from the WSU College of Pharmacy. He serves on numerous editorial boards and reviews and edits more than 30 papers each year.
Campbell is an international leader in the field of diabetes. He also has a personal interest in the disease. He was diagnosed with Type I diabetes more than 54 years ago and is one of the longest continuous users of an insulin pump in the world.
To ensure that Professor Campbell's legacy is maintained, WSU is establishing an "endowed chair" in his name. Congratulations to Keith and the Washington State University College of Pharmacy for their leadership in the field of diabetes education.
In light of this important work, I recommend that readers review clinical pharmacy services to this key patient group at their facilities. Are you providing up-to-date information on evidence-based diabetes prevention, screening, diagnosis, treatment, and control in inpatient and outpatient areas? It is only through continual improvement of the pharmaceutical care model that we will increase the self-management skills of diabetic patients who attend ambulatory care centers. ■
